Petros Pharmaceuticals Statistics
Total Valuation
PTPI has a market cap or net worth of 83,490. The enterprise value is -8.85 million.
| Market Cap | 83,490 |
| Enterprise Value | -8.85M |
Important Dates
The last earnings date was Thursday, May 22, 2025.
| Earnings Date | May 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTPI has 2.14 million shares outstanding. The number of shares has increased by 395.87% in one year.
| Current Share Class | 2.14M |
| Shares Outstanding | 2.14M |
| Shares Change (YoY) | +395.87% |
| Shares Change (QoQ) | +187.34% |
| Owned by Insiders (%) | 3.88% |
| Owned by Institutions (%) | 9.18% |
| Float | 2.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.30 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.81 |
Financial Position
The company has a current ratio of 0.53
| Current Ratio | 0.53 |
| Quick Ratio | 0.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.28 |
Financial Efficiency
Return on equity (ROE) is -2,866.76% and return on invested capital (ROIC) is -138.59%.
| Return on Equity (ROE) | -2,866.76% |
| Return on Assets (ROA) | -26.74% |
| Return on Invested Capital (ROIC) | -138.59% |
| Return on Capital Employed (ROCE) | 107.61% |
| Revenue Per Employee | 284,002 |
| Profits Per Employee | -1.65M |
| Employee Count | 18 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.76% in the last 52 weeks. The beta is 2.20, so PTPI's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | -99.76% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 5.94 |
| Relative Strength Index (RSI) | 26.79 |
| Average Volume (20 Days) | 33,612,367 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PTPI had revenue of 5.11 million and -29.66 million in losses. Loss per share was -52.60.
| Revenue | 5.11M |
| Gross Profit | 3.90M |
| Operating Income | -10.25M |
| Pretax Income | -15.90M |
| Net Income | -29.66M |
| EBITDA | -7.43M |
| EBIT | -10.25M |
| Loss Per Share | -52.60 |
Balance Sheet
The company has 8.93 million in cash and n/a in debt, giving a net cash position of 8.93 million or 4.17 per share.
| Cash & Cash Equivalents | 8.93M |
| Total Debt | n/a |
| Net Cash | 8.93M |
| Net Cash Per Share | 4.17 |
| Equity (Book Value) | -9.58M |
| Book Value Per Share | -4.67 |
| Working Capital | -12.67M |
Cash Flow
In the last 12 months, operating cash flow was -3.13 million and capital expenditures -24,587, giving a free cash flow of -3.15 million.
| Operating Cash Flow | -3.13M |
| Capital Expenditures | -24,587 |
| Free Cash Flow | -3.15M |
| FCF Per Share | -1.47 |
Margins
Gross margin is 76.28%, with operating and profit margins of -200.54% and -282.00%.
| Gross Margin | 76.28% |
| Operating Margin | -200.54% |
| Pretax Margin | -311.05% |
| Profit Margin | -282.00% |
| EBITDA Margin | -145.35% |
| EBIT Margin | -200.54% |
| FCF Margin | n/a |
Dividends & Yields
PTPI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -395.87% |
| Shareholder Yield | n/a |
| Earnings Yield | -35,526.68% |
| FCF Yield | -3,776.35% |
Stock Splits
The last stock split was on May 1, 2025. It was a reverse split with a ratio of 0.04.
| Last Split Date | May 1, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.04 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |